0001358403-18-000027.txt : 20180222
0001358403-18-000027.hdr.sgml : 20180222
20180222160413
ACCESSION NUMBER: 0001358403-18-000027
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20180220
FILED AS OF DATE: 20180222
DATE AS OF CHANGE: 20180222
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: HARRIGAN EDMUND
CENTRAL INDEX KEY: 0001177917
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36783
FILM NUMBER: 18632513
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BELLICUM PHARMACEUTICALS, INC
CENTRAL INDEX KEY: 0001358403
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 201450200
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
BUSINESS PHONE: (832) 384-1100
MAIL ADDRESS:
STREET 1: 2130 WEST HOLCOMBE BOULEVARD
STREET 2: SUITE 800
CITY: HOUSTON
STATE: TX
ZIP: 77030
FORMER COMPANY:
FORMER CONFORMED NAME: BELLICUM PHARMACEUTICALS INC
DATE OF NAME CHANGE: 20060405
4
1
wf-form4_151933343834183.xml
FORM 4
X0306
4
2018-02-20
0
0001358403
BELLICUM PHARMACEUTICALS, INC
BLCM
0001177917
HARRIGAN EDMUND
C/O BELLICUM PHARMACEUTICALS, INC.
2130 W. HOLCOMBE BLVD., STE. 800
HOUSTON
TX
77030
1
0
0
0
Stock Option (right to buy)
6.91
2018-02-20
4
A
0
20000
0
A
2028-02-19
Common Stock
20000.0
20000
D
Stock Option (right to buy)
6.91
2018-02-20
4
A
0
3166
0
A
2028-02-19
Common Stock
3166.0
23166
D
The stock option vests and becomes exercisable in 36 equal monthly installments from the date of grant, and will vest in full upon a change in control.
The stock option vests and becomes exercisable in equal installments on each of March 20, April 20, May 20, and June 14, 2018, and will vest in full upon a change in control.
/s/ Alan Musso, Attorney-in-Fact
2018-02-22